CABERGOLINE - AN ADVANCE IN DOPAMINERGIC THERAPY

被引：13

作者：

BEVAN, JS ^{[1
]}

DAVIS, JRE ^{[1
]}

机构：

[1] MANCHESTER ROYAL INFIRM,DEPT ENDOCRINOL,MANCHESTER M13 9WL,LANCS,ENGLAND

来源：

CLINICAL ENDOCRINOLOGY | 1994年 / 41卷 / 06期

关键词：

D O I：

10.1111/j.1365-2265.1994.tb02782.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：709 / 712

页数：4

共 29 条

[1] DOPAMINE AGONISTS AND PITUITARY-TUMOR SHRINKAGE [J].

BEVAN, JS ;

WEBSTER, J ;

BURKE, CW ;

SCANLON, MF .

ENDOCRINE REVIEWS, 1992, 13 (02) :220-240

[2]

BEVAN JS, 1993, ENDOCRINE REV MONOGR, V1, P211

[3] PLEUROPULMONARY DISEASE ASSOCIATED WITH DOPAMINE AGONIST THERAPY [J].

BHATT, MH ;

KEENAN, SP ;

FLEETHAM, JA ;

CALNE, DB .

ANNALS OF NEUROLOGY, 1991, 30 (04) :613-616

[4] EFFECTS OF THE DOPAMINE AGONIST CV 205-502 IN HUMAN PROLACTINOMAS RESISTANT TO BROMOCRIPTINE [J].

BRUE, T ;

PELLEGRINI, I ;

GUNZ, G ;

MORANGE, I ;

DEWAILLY, D ;

BROWNELL, J ;

ENJALBERT, A ;

JAQUET, P .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (03) :577-584

[5] EFFECTIVENESS AND TOLERABILITY OF LONG-TERM TREATMENT WITH CABERGOLINE, A NEW LONG-LASTING ERGOLINE DERIVATIVE, IN HYPERPROLACTINEMIC PATIENTS [J].

CICCARELLI, E ;

GIUSTI, M ;

MIOLA, C ;

POTENZONI, F ;

SGHEDONI, D ;

CAMANNI, F ;

GIORDANO, G .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (04) :725-728

[6] LONG-TERM TREATMENT WITH ORAL SINGLE ADMINISTRATION OF BROMOCRIPTINE IN PATIENTS WITH HYPERPROLACTINEMIA [J].

CICCARELLI, E ;

MAZZA, E ;

GHIGO, E ;

GUIDONI, F ;

BARBERIS, A ;

MASSARA, F ;

CAMANNI, F .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1987, 10 (01) :51-53

[7] DOPAMINERGIC TREATMENTS FOR HYPERPROLACTINEMIA [J].

CROSIGNANI, PG ;

FERRARI, C .

BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1990, 4 (03) :441-455

[8] INHIBITORY EFFECT OF CABERGOLINE ON THE DEVELOPMENT OF ESTROGEN-INDUCED PROLACTIN-SECRETING ADENOMAS OF THE PITUITARY [J].

DALLARA, A ;

LIMA, L ;

COCCHI, D ;

DISALLE, E ;

CANCIO, E ;

DEVESA, J ;

MULLER, EE .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (01) :97-102

[9] CABERGOLINE - LONG-ACTING ORAL TREATMENT OF HYPERPROLACTINEMIC DISORDERS [J].

FERRARI, C ;

MATTEI, A ;

MELIS, GB ;

PARACCHI, A ;

MURATORI, M ;

FAGLIA, G ;

SGHEDONI, D ;

CROSIGNANI, PG .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (06) :1201-1206

[10] CABERGOLINE IN THE LONG-TERM THERAPY OF HYPERPROLACTINEMIC DISORDERS [J].

FERRARI, C ;

PARACCHI, A ;

MATTEI, AM ;

DEVINCENTIIS, S ;

DALBERTON, A ;

CROSIGNANI, P .

ACTA ENDOCRINOLOGICA, 1992, 126 (06) :489-494

← 1 2 3 →